1
|
Ragshaniya A, Kumar V, Tittal RK, Lal K. Nascent pharmacological advancement in adamantane derivatives. Arch Pharm (Weinheim) 2024; 357:e2300595. [PMID: 38128028 DOI: 10.1002/ardp.202300595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2023] [Revised: 11/17/2023] [Accepted: 11/21/2023] [Indexed: 12/23/2023]
Abstract
The adamantane moiety has attracted significant attention since its discovery in 1933 due to its remarkable structural, chemical, and medicinal properties. This molecule has a notable impact in the therapeutic field because of its "add-on" lipophilicity to any pharmacophoric moieties. As in the case of molecular hybridization, in which one pharmacophore is attached to another one(s) with a probability of increasing the biological activity, adding an adamantane unit improves the absorption distribution, metabolism and excretion properties of the resultant hybrid molecule. This review summarizes various reports highlighting the biological activities of adamantane-based synthetic compounds and their structure-activity relationship study. The information presented in this review may open up possible dimensions for adamantane-based drug development and discovery in the pharmaceutical industry after proper structural modifications.
Collapse
Affiliation(s)
- Aman Ragshaniya
- Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India
| | - Vijay Kumar
- Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India
| | - Ram Kumar Tittal
- Department of Chemistry, National Institute of Technology, Kurukshetra, Haryana, India
| | - Kashmiri Lal
- Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, India
| |
Collapse
|
2
|
Alexeev AA, Nurieva EV, Elisseev IA, Milaeva ER, Lyssenko KA, Zefirova ON. Bicyclic isothioureas for conjugation with tubulin targeted anticancer agents. MENDELEEV COMMUNICATIONS 2022. [DOI: 10.1016/j.mencom.2022.11.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
3
|
Al-Mutairi AA, Mary YS, Mary YS, Soman S, Hassan HM, Al-Alshaikh MA, El-Emam AA. Spectroscopic, Docking and MD Simulation Analysis of an Adamantane Derivative with Solvation Effects in Different Solvents. Polycycl Aromat Compd 2022. [DOI: 10.1080/10406638.2022.2086274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Aamal A. Al-Mutairi
- Department of Chemistry, College of Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia
| | | | | | - Sreejit Soman
- Stemskills Research and Education Lab Private Limited, Faridabad, Hariyana, India
| | - Hanan M. Hassan
- Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa City, Egypt
| | - Monirah A. Al-Alshaikh
- Department of Chemistry, College of Sciences, King Saud University, Riyadh, Saudi Arabia
| | - Ali A. El-Emam
- Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
| |
Collapse
|
4
|
Podophyllotoxin esters with alicyclic residues: an insight into the origin of microtubule-curling effect in cancer cells. MENDELEEV COMMUNICATIONS 2022. [DOI: 10.1016/j.mencom.2022.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
5
|
Synthesis and properties of 1-[(3-fluoroadamantan-1-yl)methyl]-3-R-ureas and 1,1′-(alkan-1,n-diyl)bis{3-[(3-fluoroadamantan-1-yl)methyl]ureas} as promising soluble epoxide hydrolase inhibitors. Russ Chem Bull 2022. [DOI: 10.1007/s11172-022-3383-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
6
|
Sadovnikov KS, Vasilenko DA, Gracheva YA, Zefirov NA, Radchenko EV, Palyulin VA, Grishin YK, Vasilichin VA, Shtil AA, Shevtsov PN, Shevtsova EF, Kuznetsova TS, Kuznetsov SA, Bunev AS, Zefirova ON, Milaeva ER, Averina EB. Novel substituted 5-methyl-4-acylaminoisoxazoles as antimitotic agents: Evaluation of selectivity to LNCaP cancer cells. Arch Pharm (Weinheim) 2022; 355:e2100425. [PMID: 35103336 DOI: 10.1002/ardp.202100425] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Revised: 12/20/2021] [Accepted: 01/11/2022] [Indexed: 11/07/2022]
Abstract
A series of novel antimitotic agents was designed using the replacement of heterocyclic cores in two tubulin-targeting lead molecules with the acylated 4-aminoisoxazole moiety. Target compounds were synthesized via heterocyclization of β-aryl-substituted vinylketones by tert-butyl nitrite in the presence of water as a key step. 4-Methyl-N-[5-methyl-3-(3,4,5-trimethoxyphenyl)isoxazol-4-yl]benzamide (1aa) was found to stimulate partial depolymerization of microtubules of human lung carcinoma A549 cells at a high concentration of 100 µM and to totally inhibit cell growth (IC50 = 0.99 µM) and cell viability (IC50 = 0.271 µM) in the nanomolar to submicromolar concentration range. These data provide evidence of the multitarget profile of the cytotoxic action of compound 1aa. The SAR study demonstrated that the 3,4,5-trimethoxyphenyl residue is the key structural parameter determining the efficiency both towards tubulin and other molecular targets. The cytotoxicity of 3-methyl-N-[5-methyl-3-(3,4,5-trimethoxyphenyl)isoxazol-4-yl]benzamide (1ab) to the androgen-sensitive human prostate adenocarcinoma cancer cell line LNCaP (IC50 = 0.301 µM) was approximately one order of magnitude higher than that to the conditionally normal cells lines WI-26 VA4 (IC50 = 2.26 µM) and human umbilical vein endothelial cells (IC50 = 5.58 µM) and significantly higher than that to primary fibroblasts (IC50 > 75 µM).
Collapse
Affiliation(s)
- Kirill S Sadovnikov
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Dmitry A Vasilenko
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Yulia A Gracheva
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Nikolay A Zefirov
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Eugene V Radchenko
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Vladimir A Palyulin
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Yuri K Grishin
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | | | - Alexander A Shtil
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation.,Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation
| | - Pavel N Shevtsov
- Institute of Physiologically Active Compounds, Chernogolovka MR, Russian Federation
| | - Elena F Shevtsova
- Institute of Physiologically Active Compounds, Chernogolovka MR, Russian Federation
| | - Tamara S Kuznetsova
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Sergei A Kuznetsov
- Institute of Biological Sciences, Cell Biology and Biosystems Technology, University of Rostock, Rostock, Germany
| | - Alexander S Bunev
- Medicinal Chemistry Center, Togliatti State University, Togliatti, Russian Federation
| | - Olga N Zefirova
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Elena R Milaeva
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| | - Elena B Averina
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
| |
Collapse
|
7
|
Zefirov NA, Mamaeva AV, Radchenko EV, Milaeva ER, Kuznetsov SA, Zefirova ON. [Conjugate of podophyllotoxin with chlorambucil: synthesis, biological testing and molecular modeling]. BIOMEDIT︠S︡INSKAI︠A︡ KHIMII︠A︡ 2021; 67:289-294. [PMID: 34142536 DOI: 10.18097/pbmc20216703289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
In the present work we have studied a novel conjugate of the DNA alkylating agent chlorambucil with podophyllotoxin, a ligand of the colchicine binding site in tubulin. The target compound was obtained by Steglich esterification of podophyllotoxin with the percentage yield of 41%. Results of biotesting carried out on the carcinoma A549 cell line revealed that at a concentration of 2 μM the conjugate caused full depolymerization of microtubules without any other effect on free tubulin. The conjugate inhibited proliferation (IC50=135±30 nM) and growth (EC50=240±30 nM) of A549 cells. The data of computer molecular docking of the novel compound into the 3D model of the colchicine binding site in α,β-tubulin and molecular dynamics modelling allowed to explain the observed difference in effects of chlorambucil-podophyllotoxin and chlorambucil-colchicine conjugates on microtubules.
Collapse
Affiliation(s)
- N A Zefirov
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Institute of Physiologically active compounds, Russian Academy of Sciences, Chernogolovka, Russia
| | - A V Mamaeva
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia
| | - E V Radchenko
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Institute of Physiologically active compounds, Russian Academy of Sciences, Chernogolovka, Russia
| | - E R Milaeva
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Institute of Physiologically active compounds, Russian Academy of Sciences, Chernogolovka, Russia
| | - S A Kuznetsov
- Institute of Biological Sciences, University of Rostock, Rostock, Germany
| | - O N Zefirova
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia; Institute of Physiologically active compounds, Russian Academy of Sciences, Chernogolovka, Russia
| |
Collapse
|
8
|
Evdokimova AV, Alexeev AA, Nurieva EV, Milaeva ER, Kuznetsov SA, Zefirova ON. N-(4-Methoxyphenyl)-substituted bicyclic isothioureas: effect on morphology of cancer cells. MENDELEEV COMMUNICATIONS 2021. [DOI: 10.1016/j.mencom.2021.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Evdokimova AV, Alexeev AA, Nurieva EV, Milaeva ER, Kuznetsov SA, Zefirova ON. N-(4-Methoxyphenyl)-substituted bicyclic isothioureas: effect on morphology of cancer cells. MENDELEEV COMMUNICATIONS 2021. [DOI: 10.1016/j.mencom.2021.04.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
10
|
Zefirov NA, Mamaeva AV, Krasnoperova AI, Evteeva YA, Milaeva ER, Kuznetsov SA, Zefirova ON. Novel analogs of 5-hydroxymethyl-2-methoxyphenyl adamantane-1-acetate: synthesis, biotesting, and molecular modeling. Russ Chem Bull 2021. [DOI: 10.1007/s11172-021-3123-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
11
|
|
12
|
Nurieva EV, Zefirov NA, Fritsch N, Milaeva ER, Kuznetsov SA, Zefirova ON. Molecular design and synthesis of new heterobivalent compounds based on chlorambucil and colchicine. MENDELEEV COMMUNICATIONS 2020. [DOI: 10.1016/j.mencom.2020.11.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|